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ABSTRACT 
Allogeneic bone marrow (BM) transplantation enables the in vivo functional assessment of 
hematopoietic cells. As pre-conditioning, ionizing radiation is commonly applied to induce BM 
depletion, however, it exerts adverse effects on the animal and can limit experimental outcome. 
Here, we provide an alternative method that harnesses conditional gene deletion to ablate c-my b 
and thereby deplete BM cells, hence allowing BM substitution without other pre -conditioning. The 
protocol results in a high level of blood chimerism after allogeneic BM transplantation, whereas 
immune cells in peripheral tissues such as resident macrophages are not replaced. Further, mice 
featuring a low chimerism after initial transplantation can undergo a second induction cycle for 
efficient deletion of residual BM cells without the necessity to re -apply donor cells. In summary, 
we present an effective c-my b-dependent genetic technique to generate BM chimeras in the 
absence of irradiation or other methods for pre-conditioning. 
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1 INTRODUCTION 
1.1 Conventional BM depletion strategies and applications 
The replacement of BM by donor hematopoietic stem cells (HSC) has become a cornerstone of today’s 
cancer therapies in human patients (Thomas et al., 1957; Bensinger et al., 2001). In a similar vein, animal 
BM chimera models have significantly enriched life science research, allowing the study of biological 
pathways that affect hematopoietic cells (Hellman and Grate, 1967). However, irradiation causes 
undesirabl e side effects in the host organism. Dependent on the dose of ionizing irradiation, it induces 
local or systemic inflammation and may lead to organ failure (Paris et al., 2001). hrough alterations of 
the hematopoietic niche, irradiation elicits leukemic transformation of non-irradiated donor HSC 
(Chamberlin et al., 1974; Duhrsen and Metcalf, 1990). In the brain, irradiation at doses necessary for BM 
myeloablation activates microglia and disrupts the blood brain barrier (Diserbo et al., 2002; Lumniczky et 
al., 2017). This causes BM -derived progenitors to enter the central nervous system  and participate in 
microglia expansion (Priller et al., 2001; Hess et al., 2004). However, in mice with an intact blood brain 
barrier, e.g. in parabiosis assays or in models shielding the head region during irradiation, BM progenitors 
do not replenish microglia (Ajami et al., 2007; Mildner et al., 2007). Likewise, epidermal Langerhans cells 
(LC) are replaced by blood monocytes in response to  radiation-induced inflammation (Ginhoux et al., 
2006), whereas they are not replaced and self-renew by local proliferation in other BM chimera models  
(Chorro et al., 2009; Greter et al., 2012; Schulz et al., 2012). Thus, irradiation is a significant confounding 
factor in experimental research. Alternative chimera models that allow BM replacement following a less 
invasive conditioning regime are therefore desirable.  
Busulfan chemotherapy is currently employed as an alternative pre-conditioning regime for BM 
transplantation in mice in the absence of i rradiation (Wiebe et al., 1992; Westerhof et al., 2000). However, 
the method seems to be less efficient than irradiation-dependent regimes in achieving a suitable level of 
chimerism for myeloid cells in peripheral blood (Kierdorf et al., 2013). Further, the alkylating agent is 
cytotoxic to HSC and non-hematological tissues causing hepatotoxicity, veno-occlusive disease, sterility, 
carcinogenicity, and alteration of immune functions (van Pel et al., 2003; Nath and Shaw, 2007). Thus, as 
with irradiation, Busulfan conditioning is troubled by severe toxicities that limit its applications. We 
therefore developed an alternative approach that allows BM transplantation without conditioning by 
irradiation or chemotherapy. This chimera model is based on the inducible deletion of the c-myb gene, and 
we here provide a detailed and optimized protocol. 
 
1.2 Role of c-Myb in hematopoiesis 
c-Myb is an essential, evolutionary conserved regulator of hematopoiesis (Soza-Ried et al., 2010). It 
controls the proliferation and differentiation of HSC necessary for the formation of a functional BM 
compartment. Absence of c-Myb results in failure of definitive hematopoiesis across species (Gewirtz and 
Calabretta, 1988; Mucenski et al., 1991; Soza-Ried et al., 2010). We and others have previously shown that 
induction of c-myb gene del etion in Mx1Cre:c-mybfl/fl mice disrupts BM hematopoiesis and leads to 
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profound reduction of all hematopoietic lineages  (Lieu and Reddy, 2009; Schulz et al., 2012). The rapid 
depletion of the HSC pool allows the transplantation of donor BM without other pre-conditioning (Schulz 
et al., 2012; Hess et al., 2013). Monocytes and granulocytes are completely replaced by  donor BM-derived 
cells, and consequently also myeloid cells within tissues that derive from BM progenitors  (Schulz et al., 
2012). In contrast, macrophage populations resident in tissues, including microglia and epidermal LC, 
remain of host origin months after transplantation. Whereas HSC-derived myeloid cells are dependent on 
c-Myb for their maintenance and renewal in adult tissues, resident macrophages persist in tissues in the 
presence of donor HSC and in the absence of c-Myb (Gomez Perdiguero et al., 2013). 
 
1.3 Development of the protoctol 
The BM transpl antation model presented here allows a detailed analysis of BM-mediated functions in 
multiple models. In addition to the replacement of host BM by donor HSCs, the here presented 
transplantation model might also be useful for competitive assays. For exampl e, researchers could 
potentially address functions of HSCs from different donors by injecting them simultaneously. Previously, 
distribution and engraftment of HSCs were mostly studied in parabiotic mice if adverse effects of 
irradiation were to be avoided (Bunster and Meyer, 1933; Herbert et al., 2008; Kamran et al., 2013). 
 
 
2 MATERIAL AND METHODS 
2.1 Animals 
Recipient Mx1Cre:c-mybfl/fl:CD45.2/.2 mice were of C57Bl/6J genetic background. CD45.1/.1 mice of the same 
sex and genetic background were used as BM donors to allow easy quantification of the extent of 
chimerism by flow cytometry. Donor strains with fluorescence expression in HSC-derived cells are also 
suitable for an easy quantification of c himerism. Donor and recipient mice were between 12 and 20 weeks 
of age. 
The mice are available from both public repositories as well as from commercial dealers . For example, 
Mx1Cre can be ordered from EMMA archive (strain ID: EM 01143) or The Jackson Laboratory (JAX, strain 
ID: 003556); Mybfl/fl from JAX (strain ID: 028881) or the KOMP Repository(Skarnes et al., 2011); CD45.1 
mice from the RIKEN BRC facility (strain ID: RBRC00144), Charles River (strain ID: 564) or JAX (strain ID: 
002014). This list is intended for information purposes and is not exclusive.   
All experimental animals must be handled according to governmental and institutional regulations 
regarding the use of animals for research purposes. All animal experiments  in this article were approved 
by the Government of Bavaria (Regierung von Oberbayern), Germany.  
 
2.2 Reagent Setup: poly(I:C) 
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To prepare poly(I:C) high molecular weight 50 mg (Cat. # tlrl-pic-5, InvivoGen) aliquots we recommend to 
work under sterile conditions (laminar flow cabinet). Add 50 ml of endotoxin-free physiological water 
(supplied) to the 50 mg poly(I:C) vial and heat solution for 10 minutes to 68°C (Thermomixer, Eppendorf). 
Mix by pipetting gently up and down until the poly(I:C) is completely dissol ved, then let the solution cool 
down for 1 hour at room temperature (20°C) to allow proper annealing. This preparation step is critical 
since rapid cooling strategies have a negative influence on poly(I:C) quality and decrease its effectiveness 
due to improper annealing. Additionally, the potency of poly(I:C) might vary between different providers.  
 
2.3 Antibiotic treatment 
Prophylactic antibiotic treatment was performed by adding 400 mg Sulfamethoxazol + 80 mg 
Trimethoprim (Cotrim, Cat. # PZN-03928197, Ratiopharm GmbH) to acidified drinking water (pH 2.7-3.0) 
(Duran-Struuck and Dysko, 2009). 
 
2.4 Poly(I:C)-mediated bone marrow depletion 
Transfer the poly(I:C) solution (1 µl = 1 µg) at a dose of 10 µg poly(I:C) per g BW into 1 ml syringes. Inject 
with a 26G needle into the peritoneum. Injections are carried out every other day for n= 3-5 times. 
 
2.5 Isolation of donor bone marrow 
Sacrifice the donor mouse by cervical dislocation in deep isoflurane anesthesia (Cat. # 
AP/DRUGS/220/96, CP Pharma). Isolate the bones from all surrounding tissue using a scalpel and 
transfer them into sterile PBS (Dulbecco’s Phosphate Buffered Saline, Cat. # P5493-1L, Sigma-Aldrich) in a 
Petri dish on ice (4°C). To ensure isolation of BM cells in sufficient numbers, we recommend the use of at 
least 4 bones per planned transplantation (preferably humerus and femur, however, radius and tibia can 
be used as well). Proceed with bone marrow isolation at a sterile bench. 
Cut the bone on both ends with sterile scissors to remove the epiphysis and open the BM cavity. Flush the 
bone marrow with 10-15 ml ice-cold (4°C) PBS supplemented with 2% FCS (vol/vol) (Cat. # S 0615, 
Biochrom GmbH) using a 26G needle. Prepare a single cell suspension by repetitive pipetting with a large 
(20G) needle attached to a 10 ml syringe. Pass the singl e cell suspension through a 70 µm cell strainer into 
a 15 ml Falcon tube. Centrifuge at 300 g (4°C) for 5 minutes and discard supernatant. For effi cient 
erythrocyte lysis, resuspend the cell pellet in 3 ml erythrocyte lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 
1 mM EDTA) and wait for 5 minutes at room temperature. Thereafter add 30 ml of PBS containing 2 mM 
EDTA (Cat. # 03690-100ML, Sigma-Aldrich) to stop erythrocyte lysis reaction. 
Centrifuge at 300 g (4°C) for 5 minutes and discard the supernatant. Resuspend the cell pellet in 50 -100 µl 
PBS and keep on ice. Take 1 µl of this suspension for cell counting after staining with Trypan Blue (mix 
one volume of cell suspension with one volume of Trypan blue, dead cells will appear blue under a bright 
field microscope; Cat. # T8154, Sigma-Aldrich). Adjust to the desired cell concentration in a volume of 200 
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µl (per mouse) for injection. Throughout this part of the protocol, keep cells at 4°C and avoid unnecessary 
resting periods. 
 
2.6 Bone marrow transplantation 
On the day after the l ast poly(I:C) application, inject the desired number of donor cells into recipient mice. 
We recommend to inject 10x106 cells in a volume of 200 µl PBS intravenously in the tail vein using a 26G 
needle. 
 
2.7 Analysis of chimerism 
4-6 weeks after transplantation, collect 25 µl of blood from chimeric mice into EDTA-coated tubes 
(Microvette® 100 µl, Cat. # 20.1278.100, Sarstedt AG & Co). Add 3 ml of room temperature 1x erythrocyte 
lysis buffer and incubate for 5 minutes. Erythrocyte lysis is important to allow easy identification of 
leukocyte subpopulations by flow cytometry. After 5 minutes of cell lysis, add 4 ml of PBS containing 
EDTA (2 mM) to stop erythrocyte lysis reaction and centrifuge at 300 g (4°C) for 5 minutes. Thereafter, 
stain your cell samples with desired antibodies and prepare the samples for analysis according to 
standard flow cytometry protocols.  
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
3 RESULTS 
3.1 Experimental design 
We here describe a c-myb-dependent genetic technique to generate BM chimeras in a three-step protocol 
over six weeks. The protocol involves a BM depletion period of 4-8 days by poly(I:C)-mediated disruption 
of the c-myb gene, the isolation of donor cells (1 hour) and subsequent BM transplantation (1 hour) to 
achieve a chimerism over 95% after about six weeks (Fig. 1). 
We recommend a concomitant antibiotic treatment to prevent opportunistic infections in the period of BM 
depletion. Therefore, mice are treated with Cotrim (400 mg Sulfamethoxazol + 80 mg Trimethoprim) in 
acidified drinking water (pH <3 by addition of hydrochloric acid to reduce bacterial contaminations) 
available ad libitum (Duran-Struuck and Dysko, 2009) (Fig. 1). 
 
Figure 1: Experimental design. BM depletion is achieved by repetitive injections of poly(I:C) in Mx1Cre:c-
mybfl/fl:CD45.2/.2 mice (n=3-5). CD45.1/.1 donor BM cells are isolated and injected in BM-depleted recipients 
to establish BM chimeras. 3 days prior until 30 days after the first poly(I:C) injection, transpl anted mice 
receive a prophylactic antibiotic treatment. Approximate timing is indicated in the graph. 
 
3.2 Poly(I:C)-mediated BM depletion 
Polyinosinic:polycytidylic acid (poly(I:C)) is a toll-like receptor-3 (TLR3) agonist and a potent inducer of 
the Mx1 promoter, thus enabling gene targeting in mice  (Kuhn et al., 1995). We have previously shown 
that a repetitive 7-fold injection of poly(I:C) every other day leads to deletion of BM cells and a high level 
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of chimerism for myeloid cells in peripheral blood (Schulz et al., 2012). However, earlier studies suggested 
that deletion can be achieved with three injections of poly(I:C) (Kuhn et al., 1995). In this protocol, we 
show determined that repetitive (n=3-5) injections of poly(I:C) induce efficient depletion of BM 
hematopoiesis in Mx1Cre:c-mybfl/fl mice, as demonstrated by myeloablation in peripheral blood (Fig. 2). 
 
 
Figure 2: Flow cytometry analysis and survival after BM depletion. (a) Depicted is a time line of the 
experimental procedure. (b) Blood flow cytometry profile with and without genetic c -Myb-based BM 
depletion using 4 doses of poly(I:C); analysis 2 days after last poly(I:C) injection.  (c) Survival rates after 5 
doses of poly(I:C) without BM reconstitution (n=12). 
 
3.3 Isolation and transplantation of donor HSCs 
After effective BM depletion, we isolated CD45.1/.1 donor HSCs and transferred them to CD45.2/.2 depleted 
recipients on the day after the last poly(I:C) injection. Consequently, a switch from CD45.2/.2 to CD45.1/.1 
expressing leukocyte populations is observed in peripheral blood (Fig. 3a). The chimerism of individual 
cell populations gradually increases after BM transplantation. While short-lived cells such as granulocytes 
are rapidly replaced, other cells like lymphocytes persist significantly longer (Fig. 3b).  Chimerism in 
steady state is typically analyzed 6 weeks after BM transplantation (Flomerfelt and Gress, 2016). 
 
3.4 Poly(I:C)-mediated BM transplantation prevents tissue injury 
In contrast, tissue-resident macrophages, like brain microglia and epidermal LCs, are not affected by this 
protocol and remain of recipient origin (Fig. 3c). This is of particular interest since conventional 
irradiation-based models have been shown to cause tissue injury, which leads to loss of resident 
macrophages and their repl acement by BM -derived cells (Ginhoux et al., 2006). It is noteworthy, that 
similar strategies applied in humans have led to analogue results : Lung alveolar macrophages are 
repl aced by BM-derived cells after irradiation (Thomas et al., 1976), whereas alveolar macrophages 
persist in transplanted lung tissue for many years after grafting (Eguiluz-Gracia et al., 2016). Likewise, 
human epidermal LC persist in donor skin after forearm transplantation (Petruzzo et al., 2003; Kanitakis 
et al., 2004; Kanitakis et al., 2011). Together, we here describe a protocol that allows efficient BM 
transplantation in the absence of irradiation, thereby maintaining host tissue macrophages.  
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Figure 3: Chimerism after BM transplantation. (a) Blood chimerism in control and BM-depleted mice 
(4x poly (I:C)) with subsequent BM transfer. (b) Change of chimerism in peripheral blood over time after 
BM transplantation; graph shows one representative experiment. (c) Analysis of chimerism for tissue 
macrophages in the brain (microglia) and epidermis (LC). 
 
3.5 Optimizing poly(I:C) treatment cycles 
Survival rates depend on the extent and duration of myeloablation, and is therefore associated with the 
amount of poly(I:C) treatment cycles. In our hands, we achieved a chimerism >90% with a 100% survival 
rate by applying 3 injections every other day within a 6-day treatment period (Fig. 4a, b). In comparison, 
in models of allogeneic BM transplantation using irradiation survival rates of 80-90% have been 
described (Cui et al., 2002; Guest et al., 2015). The rel ative percentage of chimerism critically depends on 
the extend of BM depletion before transplantation. Short poly(I:C) injection strategies increase survival 
rates and are associated with a lower percentage of chimerism. Vice versa, extensive poly(I:C) injections 
provide better rates of chimerism with increasing lethality. Therefore, we analy zed these two parameters 
in relation to poly(I:C) treatment cycles and identified three injections to provide optimum resul ts in our 
setting (Fig. 4a, b). 
 
3.6 Alternative protocol in case of low chimerism 
In the case of insufficient chimerism after a first (usually short) round of poly(I:C)-mediated BM depletion, 
a second round of poly(I:C) injections is possible and recommended. During this period, mice are 
protected from opportunistic infections by previously transplanted donor BM cells and can therefore be 
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easily treated with additional poly(I:C) injection cycles. This strategy increases the rate of chimerism of 
initially about 60% after two injections to almost 100% after four additional injections of poly(I:C) (Fig. 
4c). 
 
 
Figure 4: Rates of blood chimerism and survival. (a) Chimerism rate in monocyte, granulocyte and 
lymphocyte lineages is dependent on treatment duration and number of poly(I:C) injections; error bars 
indicate median  interquartile ranges. (b) Bars indicate average survival rate after bone marrow 
transplantation in relation to the amount of poly(I:C) injections (treatment duration) (at least 4 animals 
were analyzed per group). (c) Mice receiving 2x poly(I:C) injections presented a low blood chimerism and 
were re-injected with poly(I:C) in a second round of treatment (4x poly(I:C)), which effectively increased 
the level of chimerism; graph shows one representative experiment. 
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4 DISCUSSION 
We provided a detailed protocol that allows efficient generation of BM chimeras harnessing a conditional, 
c-myb-dependent HSC depl etion model. While we found three poly(I:C) injections to give optimal results, 
chimerism and survival rates might vary in dependence on various factors, such as the experience of the 
scientist in handling mice (e.g. tail vein and i.p. injections), environmental conditions (e.g. animal 
husbandry) and other factors  (e.g.  mouse genetic background).  In the following, we therefore discuss 
potential pitfalls in BM transpl antation procedures  as well as specific aspects related to the conditional 
model described here (Tab. 1). 
 
Table 1: Troubleshooting. 
Problem Possible reason Solution 
Mice suffer from 
dehydration 
Acidified drinking water might lead to 
dehydration 
 
Check quality of drinking water; acidifying the water to a 
pH < 2.7 can result in dehydration (Duran-Struuck and 
Dysko, 2009) 
Early lethality after 
poly(I:C) injection 
Infection due to i.p. injection (contaminated 
needle, injury of abdominal organs) 
Deep anesthesia and careful injection technique with 
mouse tilted head down 
Low quality of donor 
HSCs 
Donor HSCs might be contaminated or 
partially dead 
Check quality of the BM cells isolated (live/dead stain) 
We routinely transplant whole BM in this protocol. In 
case of problems with this procedure, it could be 
possible to carry out cell sorting and injection of long-
term HSC (lin-Sca-1+Kit+150+CD48-) in lower numbers 
(Gomez Perdiguero et al., 2015). 
Low level of chimerism 
Poor transplantation procedure (e.g. 
improper injection, infection) 
Revisit transplantation procedures and optimize 
technique 
Low quality of donor HSCs Optimize BM quality (see “Low quality of donor HSCs”) 
Insufficient initial BM deletion  
Optimize BM depletion strategy (see “Insufficient BM 
deletion”) 
 
Independent of the reason for a low level of chimerism 
in blood, an additional cycle of poly(I:C) treatment can 
be performed to deplete recipient BM cells (see 
“Alternative protocol in case of low chimerism”, results 
section) 
Insufficient BM 
depletion 
Poly(I:C) ineffectiveness due to wrong 
reagent or insufficient annealing 
Use reagents as presented in the protocol (check origin 
and batch), avoid rapid cooling of poly(I:C) solution after 
heating phase 
BM deletion efficiency depends on mouse 
strain 
Adapt BM deletion protocol for desired mouse strain or 
switch to alternative genetic background if possible 
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Difference in levels of 
chimerism between 
mice 
Poor i.v. injection technique  Optimize intravenous injection technique 
Heterogenous quality of injected BM 
Check quality of the BM cells isolated (live/dead stain) 
(see “Low quality of donor HSCs”) 
High lethality during 
experiment 
Mostly due to Infections (health status of 
recipient mice, husbandry conditions, 
appropriate injection technique) 
Check housing conditions and general husbandry; check 
techniques for mouse handling 
Dehydration of transplanted mice 
Problems due to acidified water (see “Mice suffer from 
dehydration”) 
Low quality of donor HSCs Optimize BM quality (see “Low quality of donor HSCs”) 
 
4.1 Level of expertise needed to implement the protocol 
The protocol requires experience in animal handling and careful daily observations for signs of sepsis. To 
ensure a sufficient standard of hygiene to obtain BM chimeras, harvesting of marrow cells should be 
performed under sterile conditions. This protocol has been successfully performed in mice between 12 
and 20 weeks of age with a body weight between 20 and 25g. It is suited for female and mal e mice. 
Possible modifications with younger mice need to be evaluated.  
 
4.2 Limitations 
(i) Potential side effects of poly(I:C) 
As discussed above, poly(I:C) induces type I interferons, thus mimicking inflammatory responses to 
systemic viral infection (Alexopoulou et al., 2001). Therefore, an increase in body temperature of 0.5-
1.0°C during a period of 3-6 hours can occur (Hopwood et al., 2009; Zhu et al., 2016). In rats, a 
temperature rise of up to 1.6°C above baseline 3 hours after poly(I:C) injection has been described 
(Fortier et al., 2004). This can be accompanied by a reduced cage activity during that time. Thereafter, 
mice should be back to normal behavior. The dose described here of 10 µg/ g body weight (BW) poly(I:C) 
injected at 2-day intervals is overall well tolerated. A reduction in the number of thymocytes, known to be 
sensitive to stress (Haeryfar and Berczi, 2001), has been described (Kuhn et al., 1995). Function of other 
organs, as analyzed by histology or flow cytometry, was not al tered (Kuhn et al., 1995; Schulz et al., 2012). 
Rather, at this lower dose poly(I:C) was reported to induce tolerance to LPS and reduce liver injury(Jiang 
et al., 2005). At 20 µg/ g BW, poly(I:C) induces focal necrosis in the liver (Dong et al., 2004)  and at 30 µg/ 
g BW injury of the small intestine has been reported (Zhou et al., 2007). Thus, the dose of the inducing 
agent poly(I:C) applied in our protocol is efficient and causes little side effects. Further, we agree with 
previous reports that its transient effects do not impair the utility of this inducible gene targeting system 
(Kuhn et al., 1995). 
(ii) Reduced housing hygiene may induce background recombination  
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Suboptimal hygiene standards as found in conventional mouse housing promotes endogenous interferon 
production, which in Mx1Cre mice can induce background recombination. This might alter the response to 
administered poly(I:C). Recombination of up to 20% in splenic tissue of untreated Mx1Cre mice has been 
reported (Kuhn et al., 1995), whereas background recombination in the BM is unknown. We therefore 
suggest that all mice are maintained under specific-pathogen-free conditions. Nevertheless, we have 
successfully applied the Mx1Cre model under conventional housing conditions in previous work (Schulz et 
al., 2012). Alternatively, researchers could switch to an inducible system that is more tightly controlled, 
however, this may come at the expense of excision rate (Feil et al., 1996). Further, background 
recombination is a feature of various mouse strains and has also been reported for estrogen (ER T) or 
tetracycline (tTA/tetO) dependent systems (Kemp et al., 2004; Bersten et al., 2015).  
(iii) Genetic model requires cross-breeding 
Whereas BM transpl antation based on irradiation or chemotherapy can be carried out with most strains 
available, our model depends on the deletion of the c-myb gene and therefore requires homozygosity of 
the floxed alleles (i.e. c-mybfl/fl) in mice as well as the presence of an inducible deleter Cre (e.g.  Mx1Cre). 
Therefore, cross-breeding is required to establish this strain. However, all mice discussed in this protocol 
are available both from public repositories as well as from commercial dealers (see method section).  
 
4.3 Scope and applicability  
The c-myb-dependent transplantation model described here is efficient in generating BM chimeric mice. 
Further, macrophages are not repl aced in tissues following BM transplantation, which allows to 
adequately address their biological functions. The latter represents an important issue, since 
macrophages have been shown to populate most organs during early fetal development and are 
maintained by limited self-renewal (Schulz et al., 2012; Hashimoto et al., 2013; Yona et al., 2013; Mass et 
al., 2016; Mass et al., 2017). Both their ontogeny as well as the local organ environment contribute to 
shaping the cellular identity of tissue-resident macrophages (Gosselin et al., 2014; Lavin et al., 2014). The 
here presented BM transplantation model takes the biology of these important immune cells into account, 
since BM progenitor cells but not mature macrophages in tissues are affected by loss of c-myb (White and 
Weston, 2000; Schulz et al., 2012; Jin et al., 2016). Therefore, the chimera model presented here has a 
broad range of applications.  
Further, we expect that the protocol can be modified by employing the conditional deletion of other 
transcription factors regul ating hematopoiesis downstream of c-Myb. For example, Cited2 is critical for 
HSC maintenance in humans and mice, and is activated by c-Myb (Zhao et al., 2011). Conditional deletion 
of the Cited2 gene in mice results in loss of HSC and BM failure, phenocopying the disruption of c-myb 
(Kranc et al., 2009). Further, Cited2fl/fl mice are publically available to scientists through public resources, 
e.g. EMMA archive (stock ID: EM 03111). This further extends the applicability of the model.  
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